Wilmington Pharmaceuticals
Wilmington Pharmaceuticals develops and licenses fast-dissolve drug formulations for easy patient administration.
Founded
2002Wilmington Pharmaceuticals develops and licenses fast-dissolve drug formulations for easy patient administration.
Founded with a mission to enhance patient convenience and medication adherence, Wilmington Pharmaceuticals develops and licenses innovative fast-dissolve drug formulations. Their core vision is to revolutionize drug delivery systems, making medication administration simpler and more effective. The company focuses on creating formulations that dissolve quickly, catering primarily to patients in the United States who require easier dosing options.
Wilmington Pharmaceuticals has garnered attention for its cutting-edge delivery technologies, which have significantly impacted patient care. While specific notable affiliated people and investors are not publicly detailed, the company's achievements in formulation development have positioned it as a key player in the pharmaceutical industry. Their advancements contribute to improved patient outcomes and set new standards in drug administration.
Companies similar to Wilmington Pharmaceuticals include Concours Pharmaceuticals, NovaDel Pharma, Fidelis Pharmaceuticals and Accu-Break Pharmaceuticals.
Wilmington Pharmaceuticals was founded in 2002.
Wilmington Pharmaceuticals' headquarters is located in Wilmington, NC, US.
Wilmington Pharmaceuticals' most recent funding round was for $1.3M (USD) in October 2006.
As of Oct 26, 2006, Wilmington Pharmaceuticals has disclosed funding of $1.3M (USD). Undisclosed round amounts are excluded.
Wilmington Pharmaceuticals has 1 employee as of Feb 5, 2024.
Accu-Break Pharmaceuticals
accubreak.com
